Thymocyte development in the absence of pre-T cell receptor extracellular immunoglobulin domains

Science

Volumn 280, Issue 5365, 1998, Pages 905-908

  Irving, Bryan A ^a   Alt, Frederick W ^b   Killeen, Nigel ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN PRECURSOR; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL MATURATION; HUMAN; HUMAN CELL; IMMUNOGLOBULIN GENE; LIGAND BINDING; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; THYMOCYTE; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD3; DIMERIZATION; DNA-BINDING PROTEINS; GENE REARRANGEMENT, T-LYMPHOCYTE; HUMANS; IMMUNOGLOBULINS; IMMUNOPHENOTYPING; JURKAT CELLS; LIGANDS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED STRAINS; MICE, TRANSGENIC; NFATC TRANSCRIPTION FACTORS; NUCLEAR PROTEINS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TRANSCRIPTION FACTORS; TRANSFECTION;

ANIMALIA; MURINAE; MUS MUSCULUS;

EID: 0032496362     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.280.5365.905     Document Type: Article

References (48)

1. C. Saint-Ruf et al., Science 266, 1208 (1994).
2. H. von Boehmer and H. J. Fehling, Annu. Rev. Immunol. 15, 433 (1997).
3. H. J. Fehling, A. Krotkova, C. Saint-Ruf, H. von Boehmer, Nature 375, 795 (1995).
4. A. M. Cheng et al., Proc. Natl. Acad. Sci. U.S.A. 94, 9797 (1997).
5. T. Groves et al., Immunity 5, 417 (1996).
6. N. S. van Oers, B. Lowin-Kropf, D. Finlay, K. Connolly, A. Weiss, ibid., p. 429.
7. S. D. Levin, S. J. Anderson, K. A. Forbush, R. M. Perlmutter, EMBO J. 12, 1671 (1993).
8. T. J. Molina et al., Nature 357, 161 (1992).
9. P. Mombaerts et al., ibid. 360, 225 (1992).
10. P. Mombaerts et al., Cell 68, 869 (1992).
11. P. Mombaerts, S. J. Anderson, R. M. Perlmutter, T. W. Mak, S. Tonegawa, Immunity 1, 261 (1994).
12. Y. Shinkai et al., Science 259, 822 (1993).
13. M. Groettrup et al., Cell 75, 283 (1993).
14. C. C. O'Shea, A. P. Thornell, I. R. Rosewell, B. Hayes, M. J. Owen, Immunity 7, 591 (1997).
15. T were cloned into the p1017 expression vector, which includes the Lck proximal promoter and the human growth hormone 3′-untranslated region (42).
16. S. M. Hedrick, and F. J. Eidelman, in Fundamental Immunology, W. E. Paul, Ed. (Raven, New York, 1993), pp. 383-420.
17. N. Manolios, O. Kemp, Z. G. Li, Eur. J. Immunol. 24, 84 (1994).
18. P. Mombaerts, C. Terhorst, T. Jacks, S. Tonegawa, J. Sancho, Proc. Natl. Acad. Sci. U.S.A. 92, 7420 (1995).
19. -/- blastocysts to produce chimeric mice according to standard procedures (43).
20. T. Crompton, M. Moore, H. R. MacDonald, B. Malissen, Eur. J. Immunol. 24, 1903 (1994).
21. B. A. Irving and N. Killeen, unpublished data.
22. Y. Shinkai and F. W. Alt, Int. Immunol. 6, 995 (1994).
23. C. N. Levelt, P. Mombaerts, A. Iglesias, S. Tonegawa, K. Eichmann, Proc. Natl. Acad. Sci. U.S.A. 90, 11401 (1993).
24. W. Swat, Y. Shinkai, H. L. Cheng, L. Davidson, F. W. Alt, ibid. 93, 4683 (1996).
25. 6) were electroporated in 300 μl of serum-free RPMI 1640 medium containing 5 μg of NFAT-luciferase plasmid (44), 6 μg of v-Ras plasmid, and a total of 25 ng of pEF-Boss-based plasmids in a Bio-Rad Gene Pulser set at 240 V and 960 μF. About 6 hours after transfection, the cells were counted in a hemocytometer and plated in triplicate into 96-well plates at 200,000 cells per well. At selected times, the 96-well plates were frozen at -70°C for later analysis of luciferase activity as previously described (27).
26. P. S. Ohashi et al., Nature 316, 606 (1985).
27. J. Wu, D. G. Motto, G. A. Koretzky, A. Weiss, Immunity 4, 593 (1996).
28. A. Rao, C. Luo, P. G. Hogan, Annu. Rev. Immunol. 15, 707 (1997).
29. D. Cantrell, Ibid. 14, 259 (1996).
30. M. Woodrow, N. A. Clipstone, D. Cantrell, J. Exp. Med. 178, 1517 (1993).
31. B. A. Irving and A. Weiss, Cell 64, 891 (1991).
32. H. Jacobs et al., Eur. J. Immunol. 24, 934 (1994).
33. H. Kurose, J. W. Regan, M. G. Caron, R. J. Lefkowitz, Biochemistry 30, 3335 (1991).
34. J. Wienands, O. Larbolette, M. Reth, Proc. Natl. Acad. Sci. U.S.A. 93, 7865 (1996).
35. F. Papavasiliou, M. Jankovic, S. Gong, M. C. Nussenzweig, Curr. Opin. Immunol. 9, 233 (1997).
36. A. L. Shaffer and M. S. Schlissel, J. Immunol. 159, 1265 (1997).
37. D. Corcos et al., Curr. Biol. 5, 1140 (1995).
38. K. P. Lam, R. Kuhn, K. Rajewsky, Cell 90, 1073 (1997).
39. C. Tanchot, F. A. Lemonnier, B. Pérarnau, A. A. Freitas, B. Rocha, Science 276, 2057 (1997).
40. T. P. Hopp et al., Biotechnology 6, 1205-10 (1988).
41. G. I. Evan, G. K. Lewis, G. Ramsay, J. M. Bishop, Mol. Cell Biol. 5, 3610 (1985).
42. K. E. Chaffin et al., EMBO J. 9, 3821 (1990).
43. B. Hogan, R. Beddington, F. Costantini, E. Lacy, Manipulating the Mouse Embryo, a Laboratory Manual (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, ed. 2, 1994).
44. D. B. Durand et al., Mol. Cell. Biol. 8, 1715 (1988).
45. Single-cell suspensions of thymocytes were stained with the following antibodies (purchased from Caltag, Pharmingen, Becton-Dickinson, or VWR) in phosphate-buffered saline plus 0.3% bovine serum albumin: antibody to CD4 (anti-CD4) (CT-CD4-Tricolor), anti-CD8 [53-6.7-fluorescein isothiocyanate (FITC)], anti-TCRβ [H57-597-phycoerythrin (PE)], anti-CD25 (7D4-FITC), anti-Flag (M2), anti-Myc epitope (9E10), and anti-CD3ε (145-2C11-PE). Jurkat transfectants were stained with Leu 4 (anti-human CD3ε), followed by FITC-conjugated goat antibody to mouse IgG. Stained cells were analyzed with a Becton-Dickinson FACScan and CellQuest software. Dead cells were excluded by gating on the forward and side scatter.
46. A. Krotkova, H. von Boehmer, H. J. Fehling, J. Exp. Med. 186, 767 (1997).
47. G. J. Kersh, F. F. Hooshmand, S. M. Hedrick, J. Immunol. 154, 5706 (1995).
48. -/- ES cells; and J. D. Scarborough for help with the production of transgenic mice. Supported by the Irvington Institute (B.A.I.), the Lucille P. Markey Foundation through the University of California, San Francisco, Program in Biological Sciences (N.K.), and the Howard Hughes Medical Institute (F.W.A.).